Skip to main content
Clinical Trials/NCT06188351
NCT06188351
Recruiting
Not Applicable

A Prospective, Multicenter, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of a Three Dimensional Navigation Intracardiac Guidance Kit for Atrial Septal Puncture

Tongji Hospital1 site in 1 country136 target enrollmentApril 24, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Tongji Hospital
Enrollment
136
Locations
1
Primary Endpoint
Success rate of atrial septal puncture
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study aims to evaluate the safety and efficacy of a three-dimensional navigation intracardiac guidance kit to perform atrial septal puncture in patients requiring catheter ablation, which will be compared with procedures using traditional kit for atrial septal puncture.

Detailed Description

Atrial septal puncture has become a key technique in cardiac interventional procedures. Traditional septal punctures are routinely perfomed under two-dimensioanl guidance, whic are likely to be not acurate sometimes. This study is aimed to study the safety and efficacy of a novel designed three-dimensional navigation Intracardiac guidance kit for atrial septal puncture in patients with atrial fibrillation requiring catheter ablation and to explore the possibility of transseptal without fluoroscopy using the three-dimensional positioning intracardiac guidance.

Registry
clinicaltrials.gov
Start Date
April 24, 2023
End Date
September 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yan Wang

Professor

Tongji Hospital

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with atrial fibrillation.
  • Requiring catheter ablation therapy.
  • Voluntarily sign the informed consent.

Exclusion Criteria

  • Previous atrial septal puncture.
  • Blood clots in the left atrium or left atrial appendage
  • Left atrial mucinous tumor.
  • Atrial septal defect, including previous surgical correction or interventional occlusion.
  • Acute or severe systemic infection.
  • Cardiac function (NYHA classification) Ⅲ-Ⅳ.
  • Contraindications to anticoagulation.
  • Left ventricular ejection fraction \<35%.
  • Patients with untreated or uncontrolled hyperthyroidism or hypothyroidism.
  • Patients with malignancy with expected survival of less than 1 year.

Outcomes

Primary Outcomes

Success rate of atrial septal puncture

Time Frame: one day

Successful atrial septal puncture is defined as the right and left interatrial pathways are established and the ablation catheter can enter the left atrium smoothly for subsequent ablation operations.

X-Ray exposure time

Time Frame: one day

X-ray exposure time from the successful femoral vein puncture to the entry of the external sheath into the left atrium (ending with heparin saline flushing of the sheath).

Secondary Outcomes

  • First puncture success rate of atrial septum(one day)
  • Total operation time(one day)
  • Performance evaluation of a three-dimensional positioning intracardiac guidance kit(one day)
  • Atrial septal puncture duration(one day)

Study Sites (1)

Loading locations...

Similar Trials